672 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

BLCM

Bellicum Pharmaceuticals
US$0.075-18.2%-91.6%US$879.5kUS$5.00PE-0.04xn/an/a

FIXX

Homology Medicines
US$16.823.8%-6.5%US$54.3mUS$27.00PS47xn/an/a

AVDL

Avadel Pharmaceuticals
US$16.772.2%76.5%US$1.6bUS$22.90PS54.3xE56.7%n/a

BPMC

Blueprint Medicines
US$90.49-1.9%106.6%US$5.6bUS$97.38PS22.2xE66.2%n/a

RGC

Regencell Bioscience Holdings
US$3.67-5.0%-86.9%US$49.3mn/aPB4xn/an/a

GOVX

GeoVax Labs
US$1.88-3.1%-82.2%US$4.2mUS$105.00PB0.7xn/an/a

MYGN

Myriad Genetics
US$20.26-0.2%-9.5%US$1.9bUS$24.50PS2.4xE68.1%n/a

NCNA

NuCana
US$0.24-9.8%-73.0%US$12.4mUS$4.79PB0.7xE41.4%n/a

LEGN

Legend Biotech
US$55.49-1.6%9.9%US$10.3bUS$86.32PS35.4xE61.7%n/a

PHIO

Phio Pharmaceuticals
US$0.68-2.6%-87.2%US$3.1mUS$4.00PB0.4xn/an/a

CYRX

Cryoport
US$18.12-1.2%-10.6%US$925.8mUS$18.33PS3.8xE31.4%n/a

TXMD

TherapeuticsMD
US$2.11-5.2%-41.9%US$24.8mn/aPS18.7xn/an/a

YS

YS Biopharma
US$0.906.9%-40.4%US$160.1mUS$4.29PS2.2xE56.6%n/a

CMRA

Comera Life Sciences Holdings
US$0.0414.3%-94.7%US$1.2mn/aPS1.2xn/an/a

VRPX

Virpax Pharmaceuticals
US$3.66-12.0%-51.5%US$4.1mUS$20.00PB2.2xE47.8%n/a

SCPH

scPharmaceuticals
US$4.78-8.3%-49.9%US$181.0mUS$19.50PS12.7xE59.8%n/a

YCBD

cbdMD
US$1.0011.1%-87.0%US$3.0mUS$2.00PB0.4xE107.1%n/a

SONN

Sonnet BioTherapeutics Holdings
US$1.970.8%-76.1%US$6.0mUS$12.50PS46.8xE-24.8%n/a

HCWB

HCW Biologics
US$1.54-7.2%6.2%US$60.5mUS$4.00PS20.5xE-5.0%n/a

CRL

Charles River Laboratories International
US$247.49-4.6%22.8%US$13.2bUS$270.67PE26.8xE11.4%n/a

ATXI

Avenue Therapeutics
US$0.150.4%-86.9%US$6.5mUS$16.38PB4.2xE7.9%n/a

DMTK

DermTech
US$0.65-4.4%-84.9%US$23.0mUS$2.75PS1.5xE17.6%n/a

PXMD

PaxMedica
US$0.43-20.2%-98.5%US$3.4mUS$3.00PB0.9xn/an/a

MYMD

MyMD Pharmaceuticals
US$2.7522.2%-93.9%US$5.7mn/aPB0.5xn/an/a
Page 28 of 28
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.